Research is being conducted on advancements in bioengineering for descemet membrane endothelial keratoplasty (DMEK), a treatment for corneal issues. Studies are exploring various aspects of DMEK, including injectable cell therapy, risk factors for endothelial cell loss, and innovations in treatment. New devices and technologies, such as preloaded DMEK systems and double port injector devices, are also being developed to improve DMEK outcomes.